Sort
261,768 grants matching “gene therapy”
Deciphering the impact of sex in early subtype C HIV infection and during HART
$848,786Eric Hunter · Emory University · R01 · FY2023 · AI
Natural History of Familial Carcinoid Tumor
$848,716Stephen Wank · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Impact of Zika Virus Infection on Fetal Innate and Adaptive Immunity
$848,689Kristina M Adams Waldorf · University Of Washington · R01 · FY2024 · AI
NRSA Training Core
$848,668Emma Anne Meagher · University Of Pennsylvania · TL1 · FY2021 · TR
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$848,658Alan David Levine · Case Western Reserve University · R01 · FY2018 · DA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$848,658Alan David Levine · Case Western Reserve University · R01 · FY2019 · DA
Project 1
$848,621Darius Ebrahimi-Fakhari · Boston Children'S Hospital · U54 · FY2025 · NS
Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer
$848,580Hartmut Land · University Of Rochester · R35 · FY2019 · CA
Mechanisms of Therapy and Model Development in Hepatitis C and Liver Diseases
$848,413T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Poxvirus Gene Expression and DNA Replication
$848,411Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Signal Transduction Events and the Regulation of Cell Growth
$848,376Jane Neckers · Division Of Clinical Sciences - Nci · ZIC · FY2017 · CA
eCD4-Mediated Control of SIV Infection in the Brain
$848,349Michael R. Farzan · Boston Children'S Hospital · R01 · FY2024 · NS
Preclinical development of an immunomodulatory agent capable of mitigating influenza related hypercytokinemia
$848,308Jodi K Craigo · Cytoagents, Inc. · R44 · FY2020 · AI
Bioinformatics: Characterizing Brain Tumor Data
$848,283Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Mosaic: post-zygotic mutations in vascular malformations
$848,274James T Bennett · Seattle Children'S Hospital · R01 · FY2024 · HL
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
$848,214Mark Scott Sundrud · Dartmouth-Hitchcock Clinic · R01 · FY2024 · AI
Clinical Development of Therapies for Neurofibromatosis Type 1-Related Tumors
$848,196Brigitte Widemann · Basic Sciences · Z01 · FY2007 · CA
Immune interventions in SIV-infected ART-suppressed infant macaques
$848,161Ann M Chahroudi · Emory University · R01 · FY2019 · AI
Repair of localized DNA damage
$848,098Michael Seidman · National Institute On Aging · ZIA · FY2016 · AG
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$848,075Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2024 · CA
Structure and Function of C. Difficile Toxins
$848,063Min Dong · Boston Children'S Hospital · R01 · FY2018 · AI
Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children
$848,034Max A Seibold · National Jewish Health · R01 · FY2019 · HL
Electrical stimulation to reduce pain and improve function after knee replacement
$847,962Joseph Wilder Boggs · Spr Therapeutics, Llc · R44 · FY2017 · AG
Immunologic correlates of functional cure of HBV with immune checkpoint blockade
$847,913Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2020 · AI
Platform Technologies for Microscopic Retinal Imaging: Development & Translation
$847,874Alfredo Dubra · Stanford University · U01 · FY2018 · EY